Hancock Jaffe Laboratories to Present at The MicroCap Conference on October 2, 2018 in New York City
September 28, 2018 06:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Sept. 28, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, today...
Hancock Jaffe Submits Application to INVIMA for First-In-Human VenoValve Trial in Colombia
September 24, 2018 06:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
Hancock Jaffe to Present at Fourth Annual Robins Equity Research Roundup Conference
September 20, 2018 06:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
New Study Confirms Significant Potential U.S. Market for Hancock Jaffe’s VenoValve®
September 17, 2018 06:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health, has...
Hancock Jaffe Laboratories’ VenoValve Featured in Journal of Vascular Surgery Venous and Lymphatic Disorders as a Future Option for Treating Deep Vein Disease
September 12, 2018 06:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Sept. 12, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in medical devices that restore cardiac and vascular health,...
Hancock Jaffe Laboratories Receives Medical Research Committee Approval for First-in-Human VenoValve Study
August 09, 2018 07:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq: HJLI, HJLIW), a company specializing in bioprosthetic medical devices that establish improved standards of...
Hancock Jaffe Laboratories Receives Ethics Committee Approval for First-in-Human VenoValve Study
July 24, 2018 07:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., July 24, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved...
Hancock Jaffe Appoints Bob Rankin as Chief Financial Officer
July 13, 2018 18:18 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., July 13, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved...
Hancock Jaffe Laboratories to Conduct Analysis for FDA Submission Package for Bioprosthetic Heart Valve
July 11, 2018 08:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved...
Hancock Jaffe Laboratories Selects Site for First-in-Human VenoValve Study
June 20, 2018 08:00 ET
|
Hancock Jaffe Laboratories, Inc.
IRVINE, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- Hancock Jaffe Laboratories, Inc. (Nasdaq:HJLI) (Nasdaq:HJLIW), a company specializing in bioprosthetic medical devices to establish improved...